| Title |
Author |
Type |
Date |
Words |
| A novel approach using DNA-repair-deficient chicken DT40 cell lines for screening and characterizing the genotoxicity of environmental contaminants. |
Ji, Kyunghee; Kogame, Toshiaki; Choi, Kyungho; Wang, Xin; Lee, Jinyoung; Taniguchi, Yoshihito; Taked |
Report |
Nov 1, 2009 |
7616 |
| New HDPE bottle resins boost ESCR & stiffness. |
|
|
Oct 1, 2009 |
329 |
| United States: Battelle Memorial Institute, wins contract for measuring chemical agents, and toxic industrial chemicals. |
|
|
Sep 6, 2008 |
101 |
| Brazil: Domestic sales of industrial chemicals down 3.08% in January-April. |
|
|
May 30, 2008 |
160 |
| U.S. coastal waters see pesticide drop; 20-year study; Industrial chemicals reduced; oil-related wastes a problem. |
|
|
May 12, 2008 |
390 |
| Atlantic Research Group Successfully Completes Work on Phase III Randomized, Multi-Center Clinical Trial Facilitating Lev Pharmaceuticals' BLA Submission. |
|
|
Sep 17, 2007 |
370 |
| Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I/II Clinical Trials with HE3286 in Diseases of Inflammation. |
|
|
Sep 17, 2007 |
1433 |
| Idera Pharmaceuticals Initiates Phase 1 Trial of IMO-2125 in Hepatitis C. |
|
|
Sep 17, 2007 |
875 |
| BioSante Pharmaceuticals to Present at Upcoming Conferences. |
|
Conference news |
Sep 17, 2007 |
335 |
| Apax Partners Acquires Qualitest Pharmaceuticals and Vintage Pharmaceuticals. |
|
|
Sep 17, 2007 |
483 |
| ALFA to Buy Eastman's PET Polymers Business, Assets in Latin America. |
|
Company overview |
Sep 17, 2007 |
459 |
| Manhattan Pharmaceuticals to Present at Informed Investors Biotech/Pharma/Healthcare On-line Forum. |
|
|
Sep 17, 2007 |
467 |
| Cyclacel Pharmaceuticals to Present at the ThinkEquity Partners 5th Annual Growth Conference. |
|
Conference news |
Sep 17, 2007 |
517 |
| Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences. |
|
Conference news |
Sep 14, 2007 |
210 |
| Hollis-Eden Pharmaceuticals Announces Schedule of Upcoming Investor Presentations and Webcasts. |
|
|
Sep 14, 2007 |
659 |
| Zacks $100K Challenge 2007 Top Player Interview features Excel Maritime Carriers, Ltd., NPS Pharmaceuticals, Odyssey Marine Exploration and Weatherford International Ltd. |
|
|
Sep 14, 2007 |
764 |
| Molecular Insight Pharmaceuticals, Inc. To Present at A.G. Edwards' Annual Emerging Growth Conference. |
|
Conference news |
Sep 13, 2007 |
454 |
| EPIX Pharmaceuticals to Present at the Maxim Group 1st Annual Growth Conference. |
|
Conference news |
Sep 13, 2007 |
361 |
| Sirtris Pharmaceuticals to Present at the ThinkEquity 5th Annual Growth Conference and Bank of America 37th Annual Investment Conference on September 18, 2007. |
|
Conference news |
Sep 13, 2007 |
434 |
| Idera Pharmaceuticals to Participate in Upcoming Conferences. |
|
Conference news |
Sep 13, 2007 |
597 |
| Zacks PEG Ratio Strategy Highlights: Aspreva Pharmaceuticals Corporation, Dynamic Materials Corp., Darwin Professional Underwriters and Superior Energy Services. |
|
|
Sep 13, 2007 |
904 |
| Valeant Pharmaceuticals Launches Bedoyecta(TM) in the United States. |
|
|
Sep 13, 2007 |
321 |
| Provectus Pharmaceuticals, Inc. to Present at the Second Annual AG Edwards 2007 Emerging Growth Conference on September 18. |
|
Conference news |
Sep 12, 2007 |
396 |
| Somaxon Pharmaceuticals to Present at the Merriman Curhan Ford 4th Annual Investor Summit and ThinkEquity Partners G5: The Growth Conference. |
|
Conference news |
Sep 12, 2007 |
278 |
| Flamel Technologies Announces Medusa(R) License Agreement with Wyeth Pharmaceuticals. |
|
|
Sep 12, 2007 |
392 |
| Nanobac Pharmaceuticals Inc. Signs Agreement with American Health Associates Clinical Laboratories to Provide Calcifying Nanoparticle Tests in the United States. |
|
|
Sep 12, 2007 |
458 |
| Cubist Pharmaceuticals to Seek Technical Correction in One of Its U.S. CUBICIN Patents. |
|
Correction notice |
Sep 12, 2007 |
855 |
| King Pharmaceuticals Reports Plan to File a Motion for Rehearing and Rehearing En Banc. |
|
|
Sep 12, 2007 |
373 |
| Windhover Information Announces Its List of Top 10 Licensable Projects in the Hottest Therapeutic Areas. |
|
|
Sep 12, 2007 |
823 |
| Hollis-Eden Pharmaceuticals Reports on Anti-Inflammatory Activity with HE3286 in Models of Diseases of Inflammation. |
|
|
Sep 12, 2007 |
1232 |
| BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction. |
|
|
Sep 11, 2007 |
1243 |
| Lev Pharmaceuticals, Inc. Phase III Clinical Update Conference Call. |
|
|
Sep 11, 2007 |
281 |
| INNOVIVE Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit. |
|
|
Sep 11, 2007 |
185 |
| BioSante Pharmaceuticals Conference Call Reminder. |
|
|
Sep 11, 2007 |
333 |
| Molecular Insight Pharmaceuticals, Inc. to Host Conference Call to Review Positive Zemiva(TM) Phase 2b Data Presented at ASNC. |
|
|
Sep 11, 2007 |
762 |
| VIA Pharmaceuticals to Present at the ThinkEquity Partners 5th Annual Growth Conference. |
|
Conference news |
Sep 11, 2007 |
182 |
| BioSante Pharmaceuticals to Host Conference Call Providing LibiGel(R) Clinical Development Update. |
|
|
Sep 10, 2007 |
341 |
| QATAR - The Regional Perspective. |
|
|
Sep 10, 2007 |
1809 |
| King Pharmaceuticals Reports Filing of Paragraph IV Certification Pertaining to AVINZA(R). |
|
|
Sep 10, 2007 |
400 |
| Sirtris Pharmaceuticals to Present at the Seventh Annual Forbes Global CEO Conference September 12, 2007. |
|
Conference notes |
Sep 10, 2007 |
440 |
| VGX Pharmaceuticals Receives $1.9 Million Contract from U.S. Government to Develop Skin Micro-Electroporation for Improved Biodefense Vaccine Efficacy. |
|
|
Sep 10, 2007 |
387 |
| Molecular Insight Pharmaceuticals, Inc. Announces Positive Results of Pilot Investigation of Zemiva(TM) in Emergency Department Setting. |
|
|
Sep 10, 2007 |
2060 |
| INNOVIVE Pharmaceuticals Acquires Exclusive Rights to Develop and Commercialize Tamibarotene in Europe. |
|
|
Sep 10, 2007 |
885 |
| Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema. |
|
|
Sep 10, 2007 |
1361 |
| CytRx Subsidiary RXi Pharmaceuticals Licenses RNA Chemistry Technologies from TriLink Biotechnologies. |
|
|
Sep 10, 2007 |
1113 |
| Quinnova Pharmaceuticals, Inc. Launches TERSI FOAM(TM). |
|
|
Sep 10, 2007 |
256 |
| RXi Pharmaceuticals Licenses RNA Chemistry Technologies from TriLink Biotechnologies. |
|
|
Sep 10, 2007 |
757 |
| Isis and Alnylam Launch Regulus Therapeutics, a Joint Venture to Discover, Develop, and Commercialize microRNA Therapeutics. |
|
|
Sep 7, 2007 |
1902 |
| Akorn Announces Submission of an ANDA Drug Product Developed Jointly with Sofgen Pharmaceuticals. |
|
|
Sep 7, 2007 |
758 |
| Hollis-Eden Pharmaceuticals Presents HE3235 Update at ASCO Breast Cancer Symposium. |
|
|
Sep 7, 2007 |
1101 |
| Zemiva(TM) Normals Database From Molecular Insight Pharmaceuticals, Inc. Enables Accurate Determination of Abnormal Heart Activity. |
|
|
Sep 7, 2007 |
1415 |
| OSI Pharmaceuticals Summarizes Data Presented on Tarceva(R) (erlotinib) at the 12th World Congress on Lung Cancer Meeting. |
|
|
Sep 7, 2007 |
1700 |
| Oscient Pharmaceuticals Receives Notice of Allowance for Ramoplanin Patent Application. |
|
|
Sep 7, 2007 |
1057 |
| RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer. |
|
|
Sep 7, 2007 |
626 |
| National Institute of Aging Funding to Study the Beneficial Effects of SIRT1 Activation on Diseases of Aging. |
|
|
Sep 6, 2007 |
735 |
| Idera Pharmaceuticals Presents Interim Data from Phase 1 Study Evaluating IMO-2055 in Combination with Gemcitabine and Carboplatin. |
|
|
Sep 6, 2007 |
1201 |
| Javelin Pharmaceuticals CEO to Provide Corporate Overview and Updates on Dyloject(TM) and PMI-150 at BioCentury NewsMakers Conference. |
|
Conference news |
Sep 6, 2007 |
1035 |
| CytRx Subsidiary RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer. |
|
|
Sep 6, 2007 |
828 |
| A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Adds to Its Xyralid(TM) Franchise with the Introduction of Xyralid(TM) Cream. |
|
|
Sep 6, 2007 |
869 |
| Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU. |
|
|
Sep 6, 2007 |
1050 |
| OSI Pharmaceuticals Announces Positive Results from a Metformin Drug Interaction Study with Its DP-IV Inhibitor, PSN9301. |
|
Clinical report |
Sep 6, 2007 |
795 |
| Salix Pharmaceuticals Announces Co-Promotion Agreement for Balsalazide. |
|
|
Sep 5, 2007 |
1534 |
| Salix Pharmaceuticals Acquires Patent-Protected Metoclopramide-Zydis(R). |
|
|
Sep 5, 2007 |
801 |
| BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development. |
|
|
Sep 5, 2007 |
394 |
| Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma. |
|
|
Sep 5, 2007 |
492 |
| Patent Application Licensed to CytRx Subsidiary RXi Pharmaceuticals Issues in Australia With Broad Claims to Expressed RNAi. |
|
|
Sep 5, 2007 |
805 |
| Kelaroo Announces Expanded Collaboration with Amylin Pharmaceuticals in Computational Hormone Discovery and Peptide Therapeutic Optimization. |
|
|
Sep 5, 2007 |
339 |
| AMAG Pharmaceuticals, Inc. to Present at Two Upcoming Healthcare Conferences. |
|
Conference news |
Sep 5, 2007 |
300 |
| Noven Pharmaceuticals to Present at Upcoming Investor Conferences. |
|
Conference news |
Sep 5, 2007 |
207 |
| Vertex Pharmaceuticals Announces Webcast of its Presentation at the Bear Stearns 20th Annual Healthcare Conference. |
|
Conference news |
Sep 5, 2007 |
185 |
| Patent Application Licensed to RXi Pharmaceuticals Issues in Australia with Broad Claims to Expressed RNAi. |
|
|
Sep 5, 2007 |
575 |
| Tibotec Pharmaceuticals Ltd Returns MIV-210 Licensing Rights to Medivir. |
|
|
Sep 4, 2007 |
85 |
| Blu Pharmaceuticals Selects SupplyScape to Manage Electronic Pedigrees. |
|
|
Sep 4, 2007 |
507 |
| BioSante Pharmaceuticals to Present at The Arch Investment Conference. |
|
Conference news |
Sep 4, 2007 |
309 |
| Next Pharmaceuticals Announces Results of Relora(R) Open Label Study. |
|
Report |
Sep 4, 2007 |
419 |
| King Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference. |
|
Conference news |
Sep 4, 2007 |
298 |
| Zacks Analyst Blog Highlights: OSI Pharmaceuticals, Merck, Novartis, Bristol-Myers Squibb and AstraZeneca. |
|
|
Aug 31, 2007 |
499 |
| The Outlook for Pharmaceuticals in Western Europe to 2012 - Forecast to Reach USD245.3 Billion. |
|
|
Aug 31, 2007 |
255 |
| CollaGenex Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2007 on September 6th. |
|
Conference news |
Aug 30, 2007 |
732 |
| Medivir to Receive Shares in Presidio Pharmaceuticals. |
|
|
Aug 30, 2007 |
253 |
| EPIX Pharmaceuticals to Present at the Thomas Weisel Partners 2007 Healthcare Conference. |
|
Conference news |
Aug 30, 2007 |
387 |
| Cubist Pharmaceuticals to Present at September Investor Conferences. |
|
Conference news |
Aug 30, 2007 |
859 |
| Valeant Pharmaceuticals to Present at Bear Stearns 20th Annual Healthcare Conference. |
|
Conference news |
Aug 29, 2007 |
181 |
| Salix Pharmaceuticals to Present at Two Investment Conferences During September. |
|
Conference news |
Aug 29, 2007 |
327 |
| Bentley Granted European Patent for Its Testosterone Gel. |
|
|
Aug 29, 2007 |
830 |
| Idera Pharmaceuticals Announces Issuance of US Patent for Novel Immunostimulatory Oligonucleotide Compositions. |
|
|
Aug 29, 2007 |
581 |
| Molecular Insight Pharmaceuticals, Inc. To Present At NewsMakers In The Biotech Industry Conference. |
|
Conference news |
Aug 29, 2007 |
506 |
| Presidio Pharmaceuticals Closes $26 Million Series B Financing. |
|
|
Aug 29, 2007 |
871 |
| Hercules Provides $1.5 Million of Equity to Inotek Pharmaceuticals Corporation, a Leading Clinical Stage Drug Development Company. |
|
|
Aug 28, 2007 |
783 |
| Nanobac Pharmaceuticals Announces Investor, Scientific, and Media Conference Call. |
|
|
Aug 28, 2007 |
274 |
| Ceragenix Pharmaceuticals Receives Frost & Sullivan Product Innovation Award for Cerashield(TM) Coating. |
|
|
Aug 28, 2007 |
1070 |
| Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board. |
|
|
Aug 28, 2007 |
1162 |
| Optimer Pharmaceuticals to Present at BioCentury NewsMakers Conference. |
|
Conference news |
Aug 28, 2007 |
326 |
| Dow unveils specialty business Dow Wolff Cellulosics. |
|
|
Aug 1, 2007 |
105 |
| Conference looks at polymers in defense. |
|
Conference news |
Aug 1, 2007 |
528 |
| Firestone Polymers. |
|
|
Aug 1, 2007 |
30 |
| Polymers Solutions. |
|
|
Aug 1, 2007 |
29 |
| Bjorn Hedlund is new global marketing director at DuPont Engineering Polymers. |
|
|
Aug 1, 2007 |
159 |
| Degussa increases prices Of HP Polymers, monomers. |
|
|
Aug 1, 2007 |
121 |
| Pharmaceuticals. |
|
|
Aug 1, 2007 |
364 |
